SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Phaarmasia - Quaterly Results

12 Aug 2024 Evaluate
A fair growth of 20.59% in the revenue at Rs. 82.92 millions was reported in the June 2024 quarter as compared to Rs. 68.76 millions during year-ago period.The Total Profit for the quarter ended June 2024 of Rs. 2.77 millions grew from Rs.-2.65 millions Operating profit Margin for the quarter ended June 2024 improved to 3.31% as compared to -1.76% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 82.92 68.76 20.59 82.92 68.76 20.59 305.93 274.90 11.29
Other Income 1.48 1.44 2.78 1.48 1.44 2.78 6.62 5.16 28.29
PBIDT 3.31 -1.76 -288.07 3.31 -1.76 -288.07 -1.58 -10.26 -84.60
Interest 0.03 0.08 -62.50 0.03 0.08 -62.50 0.44 0.45 -2.22
PBDT 3.28 -1.84 -278.26 3.28 -1.84 -278.26 -2.02 -10.71 -81.14
Depreciation 0.79 0.85 -7.06 0.79 0.85 -7.06 3.44 3.60 -4.44
PBT 2.49 -2.69 -192.57 2.49 -2.69 -192.57 -5.46 -14.31 -61.84
TAX -0.28 -0.04 600.00 -0.28 -0.04 600.00 -0.28 -1.73 -83.82
Deferred Tax -0.28 -0.04 600.00 -0.28 -0.04 600.00 -0.28 -1.73 -83.82
PAT 2.77 -2.65 -204.53 2.77 -2.65 -204.53 -5.18 -12.58 -58.82
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) 3.99 -2.56 -255.95 3.99 -2.56 -255.95 -0.52 -3.73 -86.16

Phaarmasia Share Price

107.24 0.00 (0.00%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1685.50
Dr. Reddys Lab 1223.00
Cipla 1231.55
Zydus Lifesciences 938.65
Lupin 2310.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×